Creatine supplements may contain other harmful ingredients, drugs, or contaminants
Editorial Advisory Board Member, Harvard Health Publishing Semaglutide (Ozempic, Wegovy), a GLP-1 agonist drug used to treat diabetes and obesity, may also help people with fatty liver disease, called metabolic dysfunctionassociated steatotic liver disease (MASLD)
The treatment duration should be tailored to achieve and maintain the desired weight loss while ensuring patient safety
Patients often notice changes well beyond appetite when starting GLP-1 medications such as semaglutide or tirzepatide
Both the combined results of the IVW method (OR common-effect-model = 0.43 [95%CI 0.260.72], OR random-effects-model = 0.42 [95%CI 0.240.76]) and the SMR method (OR common-effect-model = 0.97 [95%CI 0.960.99], OR random-effects-model = 0.97 [95%CI 0.951.00]) showed the consistent trend with the separate results(Fig
Understanding these mechanisms is crucial for developing strategies to mitigate stress-related liver disorders and improve overall health outcomes 4
